BRL-42715

• Description :

  BRL-42715 is a potent inhibitor of a broad range of bacterial beta-lactamases (β-lactamase) [1].

• UNSPSC :

  12352005

• Target :

  Bacterial; Beta-lactamase

• Type :

  Reference compound

• Related Pathways :

  Anti-infection

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Infection

• Assay Protocol :

  https://www.medchemexpress.com/brl-42715.html

• Solubility :

  10 mM in DMSO

• Smiles :

  O=C(C(N1C/2=O)=CS[C@]1([H])C2=C/C3=CN(C)N=N3)O[Na]

• Molecular Formula :

  C10H7N4NaO3S

• Molecular Weight :

  286.24

• References & Citations :

  [1]Coleman K, et al. In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor. Antimicrob Agents Chemother. 1989 Sep;33 (9) :1580-7.|[2]K Coleman, et al. In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor. Antimicrob Agents Chemother. 1989 Sep;33 (9) :1580-7.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [102209-75-6]